HANNAH HAUFF: Open Payments
NPI 1346541067 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$468 in 19 payments from 9 companies in 2025. Trend: 2023 $108 · 2024 $60 · 2025 $468
Food & beverage: $296Education: $172
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| ABBVIE INC. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Janssen Biotech, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $37 |
| Amgen Inc. | 2 | $30 |
| GENZYME CORPORATION | 1 | $28 |
| Kerecis Limited | 1 | $11 |
Products named: DUPIXENT, SKYRIZI, COSENTYX, TREMFYA, OTEZLA, TALTZ, ILUMYA, EBGLYSS.
Industry payments across ND — which companies pay providers there.
